Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Talking Tough On DTC: Is Viagra Letter First Of Many?

Executive Summary

FDA will be forced to act if sponsors do not rein in direct-to-consumer advertising, Acting Commissioner Crawford declared during the Pharmaceutical Compliance Congress in Washington, D.C. Nov. 15

You may also be interested in...



A Brief But Memorable Tenure: Former US FDA Commissioner Lester Crawford Dies At 83

Crawford’s time as permanent FDA commissioner lasted less than three months and ended in scandal, but with that stint and his longer stretches as acting commissioner, he oversaw the agency through several historic moments that continue to influence the current regulatory environment.

Labeling Format Differentiation Minimized By Rule Implementation Timeline

FDA's implementation timeline for the physician labeling rule may mean that advent of the new labeling format will have limited impact on currently available competing products

Labeling Format Differentiation Minimized By Rule Implementation Timeline

FDA's implementation timeline for the physician labeling rule may mean that advent of the new labeling format will have limited impact on currently available competing products

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel